Systemic availability and metabolism of colonic-derived short-chain fatty acids in healthy subjects: a stable isotope study

被引:278
作者
Boets, Eef [1 ,2 ]
Gomand, Sara V. [2 ,3 ]
Deroover, Lise [1 ,2 ]
Preston, Tom [5 ]
Vermeulen, Karen [6 ]
De Preter, Vicky [1 ,7 ]
Hamer, Henrike M. [1 ,2 ]
Van den Mooter, Guy [4 ]
De Vuyst, Luc [8 ]
Courtin, Christophe M. [2 ,3 ]
Annaert, Pieter [4 ]
Delcour, Jan A. [2 ,3 ]
Verbeke, Kristin A. [1 ,2 ]
机构
[1] Katholieke Univ Leuven, Translat Res Gastrointestinal Disorders, Leuven, Belgium
[2] Katholieke Univ Leuven, Leuven Food Sci & Nutr Res Ctr, Leuven, Belgium
[3] Katholieke Univ Leuven, Ctr Food & Microbial Technol, Leuven, Belgium
[4] Katholieke Univ Leuven, Drug Delivery & Disposit, Leuven, Belgium
[5] Univ Glasgow, Stable Isotope Biochem Lab, Scottish Univ Environm Res Ctr, Glasgow, Lanark, Scotland
[6] Univ Ghent, Dept Pathol Bacteriol & Avian Dis, Merelbeke, Belgium
[7] UC Leuven Limburg, Grp Hlth & Social Work, Leuven, Belgium
[8] Vrije Univ Brussel, Ind Microbiol & Food Biotechnol, Brussels, Belgium
来源
JOURNAL OF PHYSIOLOGY-LONDON | 2017年 / 595卷 / 02期
基金
英国生物技术与生命科学研究理事会;
关键词
colonic fermentation; metabolism; short-chain fatty acids; stable isotopes; systemic exposure;
D O I
10.1113/JP272613
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Key points: The short-chain fatty acids (SCFAs) are bacterial metabolites produced during the colonic fermentation of undigested carbohydrates, such as dietary fibre and prebiotics, and can mediate the interaction between the diet, the microbiota and the host. We quantified the fraction of colonic administered SCFAs that could be recovered in the systemic circulation, the fraction that was excreted via the breath and urine, and the fraction that was used as a precursor for glucose, cholesterol and fatty acids. This information is essential for understanding the molecular mechanisms by which SCFAs beneficially affect physiological functions such as glucose and lipid metabolism and immune function. Abstract: The short-chain fatty acids (SCFAs), acetate, propionate and butyrate, are bacterial metabolites that mediate the interaction between the diet, the microbiota and the host. In the present study, the systemic availability of SCFAs and their incorporation into biologically relevant molecules was quantified. Known amounts of 13C-labelled acetate, propionate and butyrate were introduced in the colon of 12 healthy subjects using colon delivery capsules and plasma levels of 13C-SCFAs 13C-glucose, 13C-cholesterol and 13C-fatty acids were measured. The butyrate-producing capacity of the intestinal microbiota was also quantified. Systemic availability of colonic-administered acetate, propionate and butyrate was 36%, 9% and 2%, respectively. Conversion of acetate into butyrate (24%) was the most prevalent interconversion by the colonic microbiota and was not related to the butyrate-producing capacity in the faecal samples. Less than 1% of administered acetate was incorporated into cholesterol and <15% in fatty acids. On average, 6% of colonic propionate was incorporated into glucose. The SCFAs were mainly excreted via the lungs after oxidation to 13CO2, whereas less than 0.05% of the SCFAs were excreted into urine. These results will allow future evaluation and quantification of SCFA production from 13C-labelled fibres in the human colon by measurement of 13C-labelled SCFA concentrations in blood. © 2016 The Authors. The Journal of Physiology © 2016 The Physiological Society
引用
收藏
页码:541 / 541
页数:1
相关论文
共 50 条
  • [31] A comprehensive study of the whole profiles of short-chain fatty acids in milk
    Wu, Xufang
    Wang, Fengen
    Chen, Meiqing
    Qi, Yingjie
    Song, Lin
    Zheng, Nan
    Wang, Jiaqi
    Zhang, Yangdong
    JOURNAL OF DAIRY SCIENCE, 2025, 108 (03) : 2206 - 2214
  • [32] Dynamic balancing of intestinal short-chain fatty acids: The crucial role of bacterial metabolism
    Xu, Youqiang
    Zhu, Yang
    Li, Xiuting
    Sun, Baoguo
    TRENDS IN FOOD SCIENCE & TECHNOLOGY, 2020, 100 (100) : 118 - 130
  • [33] Short-Chain Fatty Acids and Their Association with Signalling Pathways in Inflammation, Glucose and Lipid Metabolism
    He, Jin
    Zhang, Peiwen
    Shen, Linyuan
    Niu, Lili
    Tan, Ya
    Chen, Lei
    Zhao, Ye
    Bai, Lin
    Hao, Xiaoxia
    Li, Xuewei
    Zhang, Shunhua
    Zhu, Li
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2020, 21 (17) : 1 - 16
  • [34] Distinct effects of fiber and colon segment on microbiota-derived indoles and short-chain fatty acids
    Huang, Zhan
    Boekhorst, Jos
    Fogliano, Vincenzo
    Capuano, Edoardo
    Wells, Jerry M.
    FOOD CHEMISTRY, 2023, 398
  • [35] Impact of Short-Chain Fatty Acids on Glucose, Fatty Acid and Leucine Metabolism in Primary Human Myotubes
    Tingstad, Ragna Husby
    Witczak, Oliwia
    Beajani, Siver
    Seo, Seung Hee
    Lovsletten, Nils Gunnar
    Skagen, Christine
    Myhrstad, Mari Charlotte Wik
    Telle-Hansen, Vibeke Helen
    Eide, Lars
    Rustan, Arild Christian
    Aas, Vigdis
    ENDOCRINOLOGY DIABETES & METABOLISM, 2025, 8 (02)
  • [36] Anticancer Effects of Gut Microbiota-Derived Short-Chain Fatty Acids in Cancers
    Son, Mi-Young
    Cho, Hyun-Soo
    JOURNAL OF MICROBIOLOGY AND BIOTECHNOLOGY, 2023, 33 (07) : 849 - 856
  • [37] Microbiota-derived short-chain fatty acids: Implications for cardiovascular and metabolic disease
    Lu, Yingdong
    Zhang, Yang
    Zhao, Xin
    Shang, Chang
    Xiang, Mi
    Li, Li
    Cui, Xiangning
    FRONTIERS IN CARDIOVASCULAR MEDICINE, 2022, 9
  • [38] Control of lymphocyte functions by gut microbiota-derived short-chain fatty acids
    Kim, Chang H.
    CELLULAR & MOLECULAR IMMUNOLOGY, 2021, 18 (05) : 1161 - 1171
  • [39] Control of lymphocyte functions by gut microbiota-derived short-chain fatty acids
    Chang H. Kim
    Cellular & Molecular Immunology, 2021, 18 : 1161 - 1171
  • [40] Gut microbiota-derived short-chain fatty acids and hypertension: Mechanism and treatment
    Yang, Fan
    Chen, Hengwen
    Gao, Yonghong
    An, Na
    Li, Xinye
    Pan, Xiandu
    Yang, Xinyu
    Tian, Li
    Sun, Jiahao
    Xiong, Xingjiang
    Xing, Yanwei
    BIOMEDICINE & PHARMACOTHERAPY, 2020, 130